Hub biomarkers and their clinical relevance in glycometabolic disorders: A comprehensive bioinformatics and machine learning approach
Gluconeogenesis-related glycometabolic disorders exhibit considerable heterogeneity, yet changes in cytokine regulation and OS are universally present. OMD , APOA4 , and IGFBP6 may serve as hub biomarkers for gluconeogenesis-related glycometabolic disorders.
Authors
- Yan Lü (ORCID: https://orcid.org/0000-0003-3468-2241)
- Yunchen Luo (ORCID: https://orcid.org/0000-0002-9621-1720)
- Jian Zhou (ORCID: https://orcid.org/0009-0003-4166-8058)
- Bing Zhou
- Hanqi Bi
- Liping Xiang
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai First People's Hospital (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2025-06-20
- DOI
- https://doi.org/10.1097/cm9.0000000000003525
- Citations
- 2
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.61